Thomasina Waldera, ARNP - Medicare Nurse Practitioner in Panama City, FL

Thomasina Waldera, ARNP is a medicare enrolled "Nurse Practitioner" in Panama City, Florida. She graduated from nursing school in 2018 and has 6 years of diverse experience with area of expertise as Nurse Practitioner. She is a member of the group practice Florida Em-i Medical Services, Pa and her current practice location is 615 N Bonita Ave, Panama City, Florida. You can reach out to her office (for appointments etc.) via phone at (850) 747-6000.

Thomasina Waldera is licensed to practice in Florida (license number APRN9388566) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1053894170.

Contact Information

Thomasina Waldera, ARNP
615 N Bonita Ave,
Panama City, FL 32401-3623
(850) 747-6000
Not Available



Provider's Profile

Full NameThomasina Waldera
GenderFemale
SpecialityNurse Practitioner
Experience6 Years
Location615 N Bonita Ave, Panama City, Florida
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Thomasina Waldera graduated from nursing school in 2018
  NPI Data:
  • NPI Number: 1053894170
  • Provider Enumeration Date: 09/13/2018
  • Last Update Date: 02/12/2024
  Medicare PECOS Information:
  • PECOS PAC ID: 5890039945
  • Enrollment ID: I20181130001915

Medical Identifiers

Medical identifiers for Thomasina Waldera such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1053894170NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
163WE0003XRegistered Nurse - Emergency RN9388566 (Florida)Secondary
363L00000XNurse Practitioner APRN9388566 (Florida)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Ascension Sacred Heart BayPanama city, FLHospital
Ascension Sacred Heart GulfPort saint joe, FLHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Florida Em-i Medical Services, Pa39714176843

News Archive

Rapamycin enhances learning and memory in young mice

Cognitive skills such as learning and memory diminish with age in everyone, and the drop-off is steepest in Alzheimer's disease. Texas scientists seeking a way to prevent this decline reported exciting results this week with a drug that has Polynesian roots.

DURECT reports successful completion of DUR-928 Phase 1 study for acute use indications

DURECT Corporation today announced the successful completion of a Phase 1 clinical trial with an injectable formulation of DUR-928 intended for acute use indications. DUR-928 is an endogenous, small-molecule, new chemical entity (NCE), which may have broad applicability in metabolic diseases such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), and in acute organ injuries such as acute kidney injury (AKI).

Study reveals few advantages of prenatal diagnosis of cleft lip and palate

Many expectant parents look forward to routine ultrasounds as their first opportunity to "see" their baby. But the ultrasound can reveal that the fetus has unexpected medical conditions, such as a diagnosis of cleft lip and palate. Despite the emotional distress the diagnosis can bring, it can also offer the opportunity to prepare for the child's future needs. However, a study has found little difference between mothers who were given a prenatal diagnosis of cleft lip and palate and those who discovered the problem at birth.

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Thomasina Waldera allows following entities to bill medicare on her behalf.
Entity NamePanhandle Emergency Physicians A Div Of Sacred Heart Hosp Pensacola
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1215948096
PECOS PAC ID: 6608854765
Enrollment ID: O20040713001524

News Archive

Rapamycin enhances learning and memory in young mice

Cognitive skills such as learning and memory diminish with age in everyone, and the drop-off is steepest in Alzheimer's disease. Texas scientists seeking a way to prevent this decline reported exciting results this week with a drug that has Polynesian roots.

DURECT reports successful completion of DUR-928 Phase 1 study for acute use indications

DURECT Corporation today announced the successful completion of a Phase 1 clinical trial with an injectable formulation of DUR-928 intended for acute use indications. DUR-928 is an endogenous, small-molecule, new chemical entity (NCE), which may have broad applicability in metabolic diseases such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), and in acute organ injuries such as acute kidney injury (AKI).

Study reveals few advantages of prenatal diagnosis of cleft lip and palate

Many expectant parents look forward to routine ultrasounds as their first opportunity to "see" their baby. But the ultrasound can reveal that the fetus has unexpected medical conditions, such as a diagnosis of cleft lip and palate. Despite the emotional distress the diagnosis can bring, it can also offer the opportunity to prepare for the child's future needs. However, a study has found little difference between mothers who were given a prenatal diagnosis of cleft lip and palate and those who discovered the problem at birth.

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.

Read more Medical News

› Verified 2 days ago

Entity NameEmerald Coast Urgent Care Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1396865556
PECOS PAC ID: 8224125869
Enrollment ID: O20071030000310

News Archive

Rapamycin enhances learning and memory in young mice

Cognitive skills such as learning and memory diminish with age in everyone, and the drop-off is steepest in Alzheimer's disease. Texas scientists seeking a way to prevent this decline reported exciting results this week with a drug that has Polynesian roots.

DURECT reports successful completion of DUR-928 Phase 1 study for acute use indications

DURECT Corporation today announced the successful completion of a Phase 1 clinical trial with an injectable formulation of DUR-928 intended for acute use indications. DUR-928 is an endogenous, small-molecule, new chemical entity (NCE), which may have broad applicability in metabolic diseases such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), and in acute organ injuries such as acute kidney injury (AKI).

Study reveals few advantages of prenatal diagnosis of cleft lip and palate

Many expectant parents look forward to routine ultrasounds as their first opportunity to "see" their baby. But the ultrasound can reveal that the fetus has unexpected medical conditions, such as a diagnosis of cleft lip and palate. Despite the emotional distress the diagnosis can bring, it can also offer the opportunity to prepare for the child's future needs. However, a study has found little difference between mothers who were given a prenatal diagnosis of cleft lip and palate and those who discovered the problem at birth.

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.

Read more Medical News

› Verified 2 days ago

Entity NameFlorida Em-i Medical Services, Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1578746574
PECOS PAC ID: 3971417684
Enrollment ID: O20080530000546

News Archive

Rapamycin enhances learning and memory in young mice

Cognitive skills such as learning and memory diminish with age in everyone, and the drop-off is steepest in Alzheimer's disease. Texas scientists seeking a way to prevent this decline reported exciting results this week with a drug that has Polynesian roots.

DURECT reports successful completion of DUR-928 Phase 1 study for acute use indications

DURECT Corporation today announced the successful completion of a Phase 1 clinical trial with an injectable formulation of DUR-928 intended for acute use indications. DUR-928 is an endogenous, small-molecule, new chemical entity (NCE), which may have broad applicability in metabolic diseases such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), and in acute organ injuries such as acute kidney injury (AKI).

Study reveals few advantages of prenatal diagnosis of cleft lip and palate

Many expectant parents look forward to routine ultrasounds as their first opportunity to "see" their baby. But the ultrasound can reveal that the fetus has unexpected medical conditions, such as a diagnosis of cleft lip and palate. Despite the emotional distress the diagnosis can bring, it can also offer the opportunity to prepare for the child's future needs. However, a study has found little difference between mothers who were given a prenatal diagnosis of cleft lip and palate and those who discovered the problem at birth.

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.

Read more Medical News

› Verified 2 days ago

Entity NameFl-i Medical Services Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1750655106
PECOS PAC ID: 9133381809
Enrollment ID: O20120426000191

News Archive

Rapamycin enhances learning and memory in young mice

Cognitive skills such as learning and memory diminish with age in everyone, and the drop-off is steepest in Alzheimer's disease. Texas scientists seeking a way to prevent this decline reported exciting results this week with a drug that has Polynesian roots.

DURECT reports successful completion of DUR-928 Phase 1 study for acute use indications

DURECT Corporation today announced the successful completion of a Phase 1 clinical trial with an injectable formulation of DUR-928 intended for acute use indications. DUR-928 is an endogenous, small-molecule, new chemical entity (NCE), which may have broad applicability in metabolic diseases such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), and in acute organ injuries such as acute kidney injury (AKI).

Study reveals few advantages of prenatal diagnosis of cleft lip and palate

Many expectant parents look forward to routine ultrasounds as their first opportunity to "see" their baby. But the ultrasound can reveal that the fetus has unexpected medical conditions, such as a diagnosis of cleft lip and palate. Despite the emotional distress the diagnosis can bring, it can also offer the opportunity to prepare for the child's future needs. However, a study has found little difference between mothers who were given a prenatal diagnosis of cleft lip and palate and those who discovered the problem at birth.

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.

Read more Medical News

› Verified 2 days ago

Entity NameCep America Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1295442614
PECOS PAC ID: 6608056171
Enrollment ID: O20230131002198

News Archive

Rapamycin enhances learning and memory in young mice

Cognitive skills such as learning and memory diminish with age in everyone, and the drop-off is steepest in Alzheimer's disease. Texas scientists seeking a way to prevent this decline reported exciting results this week with a drug that has Polynesian roots.

DURECT reports successful completion of DUR-928 Phase 1 study for acute use indications

DURECT Corporation today announced the successful completion of a Phase 1 clinical trial with an injectable formulation of DUR-928 intended for acute use indications. DUR-928 is an endogenous, small-molecule, new chemical entity (NCE), which may have broad applicability in metabolic diseases such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), and in acute organ injuries such as acute kidney injury (AKI).

Study reveals few advantages of prenatal diagnosis of cleft lip and palate

Many expectant parents look forward to routine ultrasounds as their first opportunity to "see" their baby. But the ultrasound can reveal that the fetus has unexpected medical conditions, such as a diagnosis of cleft lip and palate. Despite the emotional distress the diagnosis can bring, it can also offer the opportunity to prepare for the child's future needs. However, a study has found little difference between mothers who were given a prenatal diagnosis of cleft lip and palate and those who discovered the problem at birth.

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.

Read more Medical News

› Verified 2 days ago

Entity NameEmergency Medicine Services Of Fl Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1043917180
PECOS PAC ID: 8426413931
Enrollment ID: O20230504001881

News Archive

Rapamycin enhances learning and memory in young mice

Cognitive skills such as learning and memory diminish with age in everyone, and the drop-off is steepest in Alzheimer's disease. Texas scientists seeking a way to prevent this decline reported exciting results this week with a drug that has Polynesian roots.

DURECT reports successful completion of DUR-928 Phase 1 study for acute use indications

DURECT Corporation today announced the successful completion of a Phase 1 clinical trial with an injectable formulation of DUR-928 intended for acute use indications. DUR-928 is an endogenous, small-molecule, new chemical entity (NCE), which may have broad applicability in metabolic diseases such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), and in acute organ injuries such as acute kidney injury (AKI).

Study reveals few advantages of prenatal diagnosis of cleft lip and palate

Many expectant parents look forward to routine ultrasounds as their first opportunity to "see" their baby. But the ultrasound can reveal that the fetus has unexpected medical conditions, such as a diagnosis of cleft lip and palate. Despite the emotional distress the diagnosis can bring, it can also offer the opportunity to prepare for the child's future needs. However, a study has found little difference between mothers who were given a prenatal diagnosis of cleft lip and palate and those who discovered the problem at birth.

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Thomasina Waldera is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Thomasina Waldera, ARNP
320 Laird Dr,
Freeport, FL 32439-4625

Ph: (850) 714-4613
Thomasina Waldera, ARNP
615 N Bonita Ave,
Panama City, FL 32401-3623

Ph: (850) 747-6000

News Archive

Rapamycin enhances learning and memory in young mice

Cognitive skills such as learning and memory diminish with age in everyone, and the drop-off is steepest in Alzheimer's disease. Texas scientists seeking a way to prevent this decline reported exciting results this week with a drug that has Polynesian roots.

DURECT reports successful completion of DUR-928 Phase 1 study for acute use indications

DURECT Corporation today announced the successful completion of a Phase 1 clinical trial with an injectable formulation of DUR-928 intended for acute use indications. DUR-928 is an endogenous, small-molecule, new chemical entity (NCE), which may have broad applicability in metabolic diseases such as nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH), and in acute organ injuries such as acute kidney injury (AKI).

Study reveals few advantages of prenatal diagnosis of cleft lip and palate

Many expectant parents look forward to routine ultrasounds as their first opportunity to "see" their baby. But the ultrasound can reveal that the fetus has unexpected medical conditions, such as a diagnosis of cleft lip and palate. Despite the emotional distress the diagnosis can bring, it can also offer the opportunity to prepare for the child's future needs. However, a study has found little difference between mothers who were given a prenatal diagnosis of cleft lip and palate and those who discovered the problem at birth.

GlaxoSmithKline may see increased sales of Relenza during the A/H1N1 2009 pandemic

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that during the A/H1N1 (swine flu) pandemic, GlaxoSmithKline could see its Relenza sales increase if Tamiflu-resistant strains of the virus spread. GlaxoSmithKline recently signed A/H1N1 2009 vaccine contracts with various governments for more than $3 billion and is donating supplies to less wealthy nations, ensuring that the company strikes a balance between profit and public health concerns.

Read more News

› Verified 2 days ago


Nurse Practitioner Nurses in Panama City, FL

Kaylyn Marie Khan, ARNP
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 3808 E 3rd St, Panama City, FL 32401
Phone: 850-785-9511    Fax: 850-763-9494
Mrs. Elizabeth Ruth Doss, ARNP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 619 N Cove Blvd, Panama City, FL 32401
Phone: 850-913-6960    Fax: 850-913-6961
Kimberly Mcconnell, CNM
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 103 E 23rd St, Panama City, FL 32405
Phone: 850-769-0338    Fax: 850-640-2195
Mrs. Linda Jolene Gemsch, ARNP
Nurse Practitioner
Medicare: Accepting Medicare Assignments
Practice Location: 2420 Jenks Ave, Suite 5, Panama City, FL 32405
Phone: 850-763-3635    Fax: 850-770-3265
Mrs. Suzanne Selley Martincak, CNM, FNP, APRN
Nurse Practitioner
Medicare: Not Enrolled in Medicare
Practice Location: 5610 Highway 2297, Panama City, FL 32404
Phone: 850-387-5111    Fax: 850-252-6166
Ms. Waneda Kay Wolfe, M.N., C.N.S., A.N.P.
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 100 Doctors Dr Ste C, Panama City, FL 32405
Phone: 850-814-8400    Fax: 850-215-8405
Robin Lynn Johnston, AGACNP
Nurse Practitioner
Medicare: Medicare Enrolled
Practice Location: 801 E 6th St Ste 606, Panama City, FL 32401
Phone: 850-804-3800    Fax: 850-608-6434

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.